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A cDNA clone encoding the sequence of human pancreatic lipase (HPL) was subcloned mto the baculovirus transfer vector pVL1392 and used 
in co-transfection of Spodoptera frugiperda (39) insect cells with wild-type Autographa californica nuclear polyhedrosis vtrus (AcNPV) DNA A 
single recombinant protein (50 kDa) secreted by St9 cells was detectable in the culture medium 24 h post-infection using both anti-HPL polyclonal 
antibodies and potentiometric measurements of lipolyttc activity. The expression level reached 40 mg/l of enzyme at 6 days. A single cation-exchange 
chromatography was sufficient to obtain a highly pure recombinant HPL as demonstrated by N-termmal sequencing, amino acid composition and 
carbohydrate analysis, as well as by mass spectrometry. These analyses revealed the production of mature protein with the correct processing of 
signal peptide and an homogenous glycosylation pattern. The kinetic properties of recombinant and native HPL were compared. Both enzymes 
showed similar profiles of interfactal activatton. inhibition by bile salts and re-acttvation by colipase. 
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1. INTRODUCTION 
Human pancreatic lipase (HPL; triacylglycerol hy- 
drolase; EC 3.1.1.3) is the main lipolytic enzyme in- 
volved in the digestion of dietary fat and represents 3% 
of the total proteins secreted by the exocrine pancreas 
[ 1,2]. Contrary to most of the pancreatic enzymes which 
are secreted as proenzymes and further activated by 
proteolytic cleavage in the small intestines, HPL is di- 
rectly secreted as an active enzyme. HPL is a 50 kDa 
glycoprotein [3] consisting of a 449 amino acid polypep- 
tide [4,5], including a high mannose or complex-type 
glycan chain N-linked to Asn’@ as found also in porcine 
pancreatic lipase [6,7]. The resolution of the HPL 3D 
structure revealed the presence of a catalytic triad 
(Ser’S’-Asp’76 -His’63) similar to that found in other 
serine hydrolases, Ser ls2 being part of the G-X-S-X-G 
consensus sequence [.5]. This structure furthermore con- 
firmed the existence of two distinct domains in HPL, as 
previously suggested [8]. 
ture. In its closed conformation, the lid prevents access 
of substrate to the active site. In the presence of a lipid- 
water interface, however, the lid is displaced to one side, 
thus exposing both the active site and a larger hydro- 
phobic surface as also demonstrated in the case of 
Rhizomucor miehei lipase [9-111. These studies have 
suggested a structural basis for ‘interfacial activation’, 
a significant property of pancreatic lipases, as described 
by Sarda et al. [12]. Whereas the rate of breakdown of 
a dilute solution of short-chain triglycerides by pancre- 
atic lipase is very slow, there is a sharp increase in the 
enzymatic activity once the substrate solubility is ex- 
ceeded. Thus, pancreatic lipases were defined as a par- 
ticular class of esterases, active on an unsoluble triglyc- 
eride substrate. 
A large N-terminal domain contains the active site 
covered by a ‘lid’ domain, as seen in the crystal struc- 
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The smaller C-terminal domain in HPL is required 
for colipase binding, as shown by the recent 3D struc- 
ture of HPL-porcine procolipase complex [ 131. In addi- 
tion to interfacial activation, pancreatic lipases are also 
characterized by their behavior in the presence of bile 
salts. They are inactive on an emulsified triglyceride 
substrate in the presence of a micellar concentration of 
bile salts. The bile salts coating of triglyceride globules 
present a negatively charged surface to the surrounding 
medium, thus inhibiting pancreatic lipase adsorption 
and activation; however, a specific lipase-anchoring 
protein present in the exocrine secretion of pancreas, 
colipase, counteracts this effect [ 14,151 through the for- 
mation of a specific 1:l complex with lipase that facili- 
tates adsorption at bile salts-covered lipid-water inter- 
faces. 
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The recent 3D structures of HPL have not only con- 
tributed considerably to the structure-function charac- 
terization of pancreatic lipases but also to that of he- 
patic and lipoprotein lipases which belong to the same 
gene family [16-181. Based on the HPL structure and 
using site-directed mutagenesis, the role of the lid do- 
main in lipoprotein lipase substrate specificity has been 
investigated [ 19,201; also chimeric hepatic/lipoprotein 
lipases were used to characterize the respective roles of 
the N- and C-terminal domains in these two lipases [21]. 
Similarly, expression of recombinant HPL and mutants 
thereof is of particular interest in order to investigate 
the role of the lid domain in interfacial activation and 
lipase-colipase interactions. 
In this report, we describe the high-level expression 
of HPL in Baculovirus-infected insect cells. The recom- 
binant enzyme (rHPL) obtained after a one-step purifi- 
cation procedure was characterized and compared to 
native HPL (nHPL). 
2. MATERIALS AND METHODS 
2.1, Materuls 
The baculovirus transfer vector, pVLl392, Autogrupha calzfornica 
nuclear polyhedrosis virus (AcMNPV) DNA, Spodopterufvugiperdu 
(39) cells, Baculovirus agarose. Grace media + supplements and Cat- 
ionic liposome solution were from lnvitrogen Corp (San Diego, CA). 
The serum-free Insect cell culture medium SF-900 II was from GIBCO 
BRL/Life Technologies (Copenhagen Denmark) Restriction endo- 
nucleases and T4 DNA ligase were purchased from New England 
Biolabs/FINNZYMES (Espoo. Finland). Mono S cation-exchange 
column was from Pharmacia LKB (Copenhagen, Denmark) Colipase 
was from Boehringer-Manheim (Manhetm. Germany) Sodium tau- 
rodeoxycholate was from Sigma (St. Louis. MO). Purum tributyrin 
was from FLUKA (Buchs. Switzerland). Native HPL and anti-HPL 
polyclonal antibodies were a generous gift from Alain De Caro and 
Robert Verger (Laboratotre de lipolyse enzymatique. CNRS 
Marseille, France) 
2.2. Production of recombwant virus 
A cDNA clone for the HPL was obtained from human placenta 
mRNA by PCR technology based upon the complete sequence of 
HPL, includmg signal peptide [4], A 1.410 bp BwIHI fragment, con- 
taining the entire codmg region of HPL, was subcloned into the 
pVL1392 transfer vector. The plasmid was purified by CsCl-gradient 
ultracentrifugation and then used for co-transfection with AcMNPV 
DNA mto St9 cells. 
Transfection was performed as described m the Baculovirus Expres- 
sion System Manual, from Invitrogen Corp. (version 1.5.5). 1 pg of 
hnear AcMNPV DNA and 3 pug of recombinant pVLl392 were trans- 
fected into St9 cells (2 x 10h cells in 60 mm dishes). The resultmg 
culture supernatant was collected after 5 days. Fresh monolayers of 
Sf9 cells in 100 mm plates were infected with virus supernatant at 
various dilutions and then overlaid with 1 5% agarose containing 
complete TNM-FH medium [22]. After 6 days recombmant plaques 
were identified as occlusion-negative (seen in a light microscope) The 
presumed recombinant plaques were used to infect 6-well plates con- 
taining Sf9 cells and after 5 days the corresponding virus DNA was 
purified and subjected to a PCR reaction with reverse and forward 
primer as previously described [23.24]. The PCR fragments from re- 
combinant plaques were also analysed by restriction enzyme digestion. 
The recombinant viruses were subjected to another round of plaque 
purification to ensure that the recombmant virus stock was free of 
wild-type virus. 
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2.3. E.~pression of rHPL in Sp cells 
The St9 cells were grown at 27°C to a concentration of 8 x lo5 
cells/ml m 250 ml SF-900 II medium using 1.000 ml screw-capped 
Erlenmeyer flask m an orbital shaker set at 80 rpm. The recombinant 
baculovirus containing the HPL cDNA was added to the cells at a 
multiplicity of mfection close to 1. Samphng was performed each day 
for 7 days m order to check cell vtabthty and measure hpase produc- 
tion After centrtfugation to remove cells and debris. hpolytic activity 
was assayed using the standard measurement of pancreatic lipases [25] 
and an aliquot was stored at -20°C for SDS-PAGE and immunoblot- 
ting. 
2.4. Pur?ficurlon of‘rHPL 
Cultures of recombinant baculovirus-infected St9 cells were har- 
vested after 3 days and cells were pelleted by centrifugation at 10,000 
rpm for 10 min. The supernatant was lyophtlyzed during 24 h and the 
dry material was dissolved in a few ml of distilled water and dialyzed 
overnight agamst 10 mM MES buffer. pH 6.5. Prior to chromatogra- 
phy. the solution was passed through a 0.8 pm Millipore filter. Usmg 
FPLC (Pharmacia). cation-exchange chromatography was performed 
on a Mono S HR 5/5 column equilibrated in 50 mM NaCI. 10 mM 
MES buffer, pH 6.5 After sample injection, a linear NaCl concentra- 
tion gradient was applied, increasing over 60 mm from 50 mM to 175 
mM NaCl m 10 mM MES buffer pH 6.5. The flow rate was adjusted 
to 1 mllmin and the pressure was maintained between 20 and 25 bar. 
The protem elution profile was recorded spectrophotometrically at 
280 nm and the lipase activity was measured potentiometrtcally in all 
fractions collected (see analytical assays). 
2.5. Anaiytwal assays 
Lipase activity m insect cell culture supernatant and m fractions 
collected during the purification procedure was measured potentto- 
metrically at pH 8 0 and 37°C using a pH-stat (TTT 80 Radiometer. 
Copenhagen). The standard assay conditions consisted of a mecham- 
tally stirred emulsion of 0.5 ml tributyrin in a thermostated reaction 
vessel containmg 14.5 ml of 0.28 mM Tris. 150 mM NaCl. I.4 mM 
CaCl,, 4 mM NaTDC [25]. Cohpase was added at a molar excess of 
2. The specific activity of nHPL was 8.000 Ulmg under these standard 
assay conditions. 1 unit (U) represents one pmol of butyric acid re- 
leased per mm. 
Electrophorests was performed on 12% SDS-polyacrylamide gels. 
Two gels were run in parellel One gel was stained with Coomasste blue 
and the second gel was transfered onto nitrocellulose membrane [26] 
and immunoblotting was performed using rabbit polyclonal antibod- 
ies raised against nHPL purified from human pancreatic mice. The 
revelation of the bound anttbodtes was done with anti-rabbit IgG- 
peroxidase conjugate and 4-chloro 1-naphtol as substrate. 
The isoelectric points of rHPL and nHPL were determmed on IEF 
339 PhastGel using the Pharmacia Phastsystem. 
Prior to N-termmal sequencmg, a sample of the purified rHPL (2.50 
~1 containing 125pg rHPL) from the Mono S column was run through 
an HPLC column. The sample was injected onto a Vydac 214TD54 
reverse-phase C4 HPLC column (0.46 x 25 cm) eqmhbrated at 30°C 
at a flow rate of I .5 ml/mm with 0.1% TFA in 20% (v/v) acetonitrile. 
The concentration of acetomtrtle in the eluting solvent was raised to 
70% (v/v) over 25 mm. Absorbance was measured at 280 nm. The 
purified rHPL eluted at a retention time of 16.2 min. correspondmg 
to 48.4% of acetonitrile. The material elutmg m the mam peak was 
collected and concentrated to 60~1 by vacuum centrifugation. Ammo 
acid sequence analysis on this sample was carried out by automated 
Edman analysis usmg an Applied Biosystem Model 470A gas-phase 
sequencer [27]. 
Amino acid composttion analysis was carried out by hydrolysis of 
50 pg rHPL with 6 M HCl for 24 h at 110°C as previously described 
1281. 
Carbohydrate composition analysis was carried out by hydrolysis 
of 50 yg rHPL wtth 2 M HCI for 1.2 and 4 h at 100°C. and monosac- 
charides were separated on a CarboPdc PA1 (Dionex. Sunyvale. CA) 
column (4 x 250 mm) eluted with 14 mM NaOH. The monosac- 
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charides were detected by pulsed amperometrtc detection (Dionex, 
PAD detector). The amount ofmonosaccharides was corrected to ttme 
zero of hydrolysis and calculated as nmol of monosaccharide per nmol 
protein. 
Electrospray mass spectrum was recorded on API III LCIMSIMS 
system (Perkin-Elmer Sciex instrument, Thornhill Canada). The triple 
quadrupole instrument has a mass-to-charge (m/z) range of 2,400 and 
is fitted with an articulated, pneumatically assisted electrospray (also 
referred to as ion-spray) interface and an atmospheric pressure toniza- 
tton source. Sample introduction was done by a syringe infusion pump 
(Sage instruments, Cambridge, MA) through a fused capillary (75 pm 
i.d.) with a liquid flow-rate set at 0.551 pl/min. The mstrument m/z 
scale was calibrated wtth selected (covermg m/z 50&2,400) ammonium 
adduct ions of poly(propylene glycols) (PPG’s) under unit resolution. 
The accuracy of mass measurements is generally better than 0 02%. 
3. RESULTS AND DISCUSSION 
3.1. Expression of puriJication of rHPL 
A timexourse experiment of rHPL expression in in- 
sect cells was carried out (Fig. 1). demonstrating that 
rHPL activity is present in the culture medium after 24 
h following infection with recombinant baculovirus. 
The activity accumulated in the medium reached a max- 
imal level of 40 ,ug/ml after 6 days, similar to yields 
previously described with the expression of pancreatic 
cholesterol esterase using the same expression system 
[29]. The activity was directly measured from the culture 
medium using tributyrin as substrate (see section 2) and 
the amount of active enzyme was deduced from its spe- 
cific activity. 
The viability of the St9 cells in the culture medium 
was also followed by light microscopy each day. A 
sharp decrease in cell viability was observed between 
day 3 and 4 (data not shown). 
(h ;Da) 
A 
94 
67 
30 
20 
Days after infection 
Fig 1. Time-dependent expression of rHPL in Sf9 cells (mean of three 
identical experiments 2 S.D.). The 39 cells were infected with recom- 
binant baculovirus containing the HPL cDNA. Each day after the 
initial Infection. an ahquot of the culture medium was removed and 
tested for rHPL expression and cell viability. Lipolytic activity was 
determmed using the pH-stat technique and tributyrin as substrate 
(see section 2). 
In parallel with the activity measurements, the rHPL 
secreted by the infected Sfp cells was analysed by SDS- 
PAGE and immunoblotting (Fig. 2A and B). We dem- 
onstrated that the patterns on the SDS gel and im- 
munoblot follow the activity measurements as rHPL 
expression increases. The rHPL was clearly the major 
protein observed at 50 kDa. At day 4 the background 
level of other proteins increased, in accordance with 
increasing cell lysis. As shown in Fig. 2B, anti-HPL 
Fig. 2. SDS-PAGE (A) and immunoblotting (B) of rHPL expressed in Sf9 cells. Each day after the initial infection of St9 cells an aliquot of the 
culture medium was removed and subjected to electrophoresis and immunoblot analysis. In panels A and B, lanes l-7 correspond to day l-7 after 
infection. Lane 8 is the purified rHPL obtamed after cation-exchange chromatography on a Mono S column. Lane 9 is nHPL purified from human 
pancreatic juice. Molecular weight markers were loaded on lane 10. 
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antibodies also reacted with lower molecular weight 
compounds appearing in the medium from day 4. These 
minor compounds might be proteolytic fragments of 
rHPL generated by proteases released from lysed cells. 
Accordingly, culture supernatants were harvested 
t 
Fig. 3. Purificatton of rHPL expressed m baculovtrus-infected insect 
cells. Pure rHPL was obtamed using FPLC and a single purificatton 
step on a Mono S HR 5/5 column (A). Protein elutton was recorded 
by measuring absorbance at 280 nm. and lipolytic activity was assayed 
in all the collected fractions using the pH-stat technique and tributyrin 
as substrate (see section 2). The fracttons containing rHPL activity 
were pooled and further subjected to HPLC analysis (B) on a reverse- 
phase column (see section 2) 
after 3 days and rHPL was purified as described (see 
section 2). As shown in Fig. 3A, a single step procedure 
using a cation-exchange column was highly efficient for 
isolating the rHPL. The solution containing rHPL was 
loaded onto a Mono S HR 5/5 column and lipolytic 
activity was assayed in the eluant in order to check for 
the absence of non-bound lipase. A linear salt gradient 
was then applied and rHPL was eluted at about 80-90 
mM NaCl. An average recovery of about 90-95% rHPL 
lipolytic activity was obtained in the fractions corre- 
sponding to the single peak observed in Fig. 3A. 
Lipolytic activity and absorbance at 280 nm were 
clearly correlated. 
The purified rHPL was analyzed by SDS-PAGE. The 
results showed a single protein of 50 kDa that co-mi- 
grated with native HPL (Fig. 2A and B, lanes 8 and 9). 
Purified rHPL was then run through an HPLC col- 
umn as described (section 2). As shown in Fig. 3B. 
rHPL recovered from the Mono S column is 98% pure. 
The isoelectric point of rHPL was found to be 7.5, 
which is identical to the p1 of the major nHPL isoform 
(data not shown) as previously reported [30-321 and 
significantly different from the value found by De Caro 
et al. [3]. 
N-Terminal sequence, KEVCYERLGCFSDDS, is 
identical to the N-terminal sequence of mature HPL 
MW: 50,543 amu 
Fig. 4. ESMS spectrum of 20 pmol purified rHPL. The mass spectrum displays a series of multtply protonated molecular tons. The molecular wetght 
of rHPL ts determined to 50.543 amu or Da. 
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Tributyrin [mM] 
Fig. 5. Interfacial actlvatlon. The influence of tributyrin concentration 
on both rHPL and nHPL was measured by the pH-stat technique. As 
indicated by the arrow, trlbutyrin saturation under the present exper- 
imental conditions is found at 0.4 mM. The assay (37°C. pH 8.0) 
contained 1 pg and 50 pg enzyme above and below trlbutyrin satura- 
tion, respectively, in 15 ml NaCl solution (150 mM) and various 
concentrations of tributyrin in the presence of a molar excess of coli- 
pase of 2. 
[4,5], confirming that rHPL is correctly N-terminally 
processed and no degradation products were observed 
either by HPLC analysis (Fig. 3B) or by N-terminal 
sequencing. 
The amino acid composition confirmed that rHPL 
consist of 449 amino acid residues corresponding to a 
molecular weight of 49,505 Da. Carbohydrate analysis 
revealed the presence of 2.59 nmol Man, 1.61 nmol 
GlcNAc and 0.69 nmol Fuc per nmol of rHPL. These 
results suggest the N-linked glycosylation pattern, 
~ Asn’66 - GlcNAc - GlcNAc - Man ’ 
Man 
Fuc 
\ 
Man 
where the glycan chain is only the core of the classical 
N-linked polysaccharides. 
The Electrospray (ES) mass spectrum of purified 
rHPL is shown in Fig. 4. It displays a series of ions 
corresponding to multiply protonated molecular ions 
(45+ to 58+). The determined molecular mass (50,543 
Da) is consistent with the theoretical value of the pol- 
ypeptide (49,505 Da) corrected for the presence of the 
proposed N-linked glycan (+1,038 Da). 
3.2. Kinetic characterisation of rHPL and comparison 
with nHPL 
Interfacial activation of HPL is shown in Fig. 5, dem- 
onstrating a sharp increase in activity when the tribu- 
tyrin reaches its saturation point (at 400 PM under the 
present experimental conditions). The measurements 
were done in the absence of bile salts and in the presence 
of colipase in order to avoid irreversible inactivation of 
HPL at the interface (see below). 
As shown in Fig. 6, rHPL and nHPL also display 
similar properties with respect to the bile salts inhibition 
above their critical micellar concentration, and to the 
restoration of activity by colipase. Without bile salts 
(NaTDC) and without colipase, rHPL and nHPL are 
irreversibly inactivated at the interface. These results 
are distinct from earlier observations with porcine pan- 
creatic lipase, which is active and stable under these 
conditions [33]. 
Using tributyrin as substrate, micellar concentrations 
of bile salts (2 mM NaTDC) and colipase in excess, we 
have measured optimal specific activity of 12,000 U/mg 
for both rHPL and nHPL in the pH range 7.0-7.5. 
Under these conditions it is possible to increase by 50% 
the specific acticity of HPL, as compared to the activity 
(8,000 U/mg) obtained under standard assay conditions 
(pH 8.0, 4 mM NaTDC, [25]). 
4. CONCLUSION 
We have shown that the baculovirus system can be 
used to produce a recombinant pancreatic lipase in sub- 
stantial yield for basic research. The enzyme is easy to 
purify in a one-step procedure. The highly purified ma- 
. n-HPL + cohpase 
A r-HPL - cohpase 
Sodium taurodeoxycholate (mM) 
Fig. 6. Sensltlvity to bile salts and colipase effect. In the absence of 
colipase (open symbols), both rHPL and nHPL are inhibited by bile 
salts concentrations above the critical micellar concentration (around 
1 mM NaTDC). In the presence of cohpase (closed symbols), the 
inhibition by bile salts of both rHPL and nHPL 1s supressed. The 
lipase specific activity was measured with the pH-stat technique at pH 
8.0 and at 37°C. The final assay volume consisted of 15 ml, containing 
0.5 ml tributyrin, 14.5 ml of 0.28 mM Tns, 150 mM NaCl, 1.4 mM 
CaCl, and various concentrations of NaTDC. The assay contained 
between 1 pg and 5 pug enzyme and a molar excess of colipase of about 
2. The asterisks (*) indicate lipolytic activities based on initial veloci- 
ties when the enzyme is inactivated at the interface during titration. 
For all the other points the kinetics of fatty acid titration were found 
to be linear, except when, in the total absence of bile salts and colipase, 
neither rHPL or nHPL displayed activity and were irreversibly inac- 
tivated. 
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terial obtained and its biochemical characterization 
similar to that of the native enzyme show that the bacu- 
lovirus expression system is promising for the expres- 
sion of pancreatic lipases, and mutants thereof, for fur- 
ther structureefunction studies. 
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